Published in J Neuroimmunol on March 27, 2010
Quantitative MRI shows cerebral microstructural damage in hemolytic-uremic syndrome patients with severe neurological symptoms but no changes in conventional MRI. Neuroradiology (2013) 0.85
Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2. MBio (2013) 0.84
Ouabain protects against Shiga toxin-triggered apoptosis by reversing the imbalance between Bax and Bcl-xL. J Am Soc Nephrol (2013) 0.83
A translational murine model of sub-lethal intoxication with Shiga toxin 2 reveals novel ultrastructural findings in the brain striatum. PLoS One (2013) 0.82
Role of Shiga/Vero toxins in pathogenesis. Microbiol Spectr (2014) 0.79
Dexamethasone rescues neurovascular unit integrity from cell damage caused by systemic administration of shiga toxin 2 and lipopolysaccharide in mice motor cortex. PLoS One (2013) 0.77
Shiga toxin type-2 (Stx2) induces glutamate release via phosphoinositide 3-kinase (PI3K) pathway in murine neurons. Front Mol Neurosci (2015) 0.77
Psychiatric symptoms in patients with Shiga toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome. PLoS One (2014) 0.77
The actions of Shiga toxin-2 administration into the brain on renal sympathetic nerve activity. Clin Exp Nephrol (2011) 0.75
Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model. Infect Immun (2006) 1.49
Negative transcriptional regulation of the mce3 operon in Mycobacterium tuberculosis. Microbiology (2002) 1.15
Regulation of hypothalamic prohormone convertases 1 and 2 and effects on processing of prothyrotropin-releasing hormone. J Clin Invest (2004) 1.13
Development and application of new mouse models to study the pathogenesis of Clostridium perfringens type C Enterotoxemias. Infect Immun (2009) 1.10
Intracerebroventricular administration of Shiga toxin type 2 induces striatal neuronal death and glial alterations: an ultrastructural study. Brain Res (2007) 1.01
Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity. Infect Immun (2008) 0.99
Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2. MBio (2013) 0.84
Hypothermia prevents gliosis and angiogenesis development in an experimental model of ischemic proliferative retinopathy. Invest Ophthalmol Vis Sci (2013) 0.83
Intracerebroventricular administration of Shiga toxin type 2 altered the expression levels of neuronal nitric oxide synthase and glial fibrillary acidic protein in rat brains. Brain Res (2008) 0.82
A translational murine model of sub-lethal intoxication with Shiga toxin 2 reveals novel ultrastructural findings in the brain striatum. PLoS One (2013) 0.82
Necrotic enteritis in young calves. J Vet Diagn Invest (2011) 0.82
Effect of tannins on the in vitro growth of Clostridium perfringens. Vet Microbiol (2010) 0.81
Intraperitoneal administration of Shiga toxin 2 induced neuronal alterations and reduced the expression levels of aquaporin 1 and aquaporin 4 in rat brain. Microb Pathog (2012) 0.81
Effects of Clostridium perfringens alpha and epsilon toxins in the bovine gut. Anaerobe (2011) 0.79
Neuromodulatory role of angiotensin-(1-7) in the central nervous system. Clin Sci (Lond) (2013) 0.79
Neostriatal cytoskeleton changes following perinatal asphyxia: effect of hypothermia treatment. Int J Neurosci (2006) 0.77
Dexamethasone rescues neurovascular unit integrity from cell damage caused by systemic administration of shiga toxin 2 and lipopolysaccharide in mice motor cortex. PLoS One (2013) 0.77
Naturally acquired antibodies against Clostridium perfringens epsilon toxin in goats. Vet Immunol Immunopathol (2008) 0.77
[Hemolytic uremic syndrome caused by enterohaemorrhagic Escherichia coli]. Arch Argent Pediatr (2008) 0.77
[Role of the Shiga toxin in the hemolytic uremic syndrome]. Medicina (B Aires) (2006) 0.76